Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Haifa K. Al-Ali, MD, Jeanett Edelmann, MD, Sabine Leiblein, PhD, Christel Mueller, Evelin Hennig, Martina Bless, Christina Franke, Dietger W. Niederwieser, MD

Blood (2005) 106 (11): 3286.

https://doi.org/10.1182/blood.V106.11.3286.3286

Published: 2005

Journal Articles

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Thoralf Lange, MD, Thomas Thielsen, Sabine Leiblein, PhD, Ruediger Alt, Guido Zschau, Ralf Burckhardt, Ines Kovacz, Haifa K. Al-Ali, MD, Christina Franke, Rainer Krahl, PhD, Dietger Niederwieser, MD, Michael W. Deininger, MD, PhD

Blood (2005) 106 (11): 1985.

https://doi.org/10.1182/blood.V106.11.1985.1985

Published: 2005

Journal Articles

Molecular Remission to Imatinib in Patients with Chronic Myeloid Leukaemia (CML) Is Less Durable Compared to Patients after Allografting.

Thoralf Lange, MD, Thomas Bumm, Marc Mueller, Sandra Otto, Haifa K. Al-Ali, MD, Leanthe Grommisch, MD, Scarlet Musiol, Christina Franke, Rainer Krahl, PHD, Dietger W. Niederwieser, Michael W. Deininger, MD, PhD

Blood (2004) 104 (11): 276.

https://doi.org/10.1182/blood.V104.11.276.276

Published: 2004

Journal Articles

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Brian J. P. Huntly, Francois Guilhot, Alistair G. Reid, George Vassiliou, Evelin Hennig, Christina Franke, Jennie Byrne, Andre Brizard, Dietger Niederwieser, Julie Freeman-Edward, Gavin Cuthbert, Nick Bown, Richard E. Clark, Elizabeth P Nacheva, Anthony R Green, Michael W. N. Deininger

Blood (2003) 102 (6): 2205–2212.

https://doi.org/10.1182/blood-2002-09-2763

Published: 2003

Journal Articles

Emergence of clonal cytogenetic abnormalities in Ph − cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

Thomas Bumm, Christel Müller, Haifa-Kathrin Al-Ali, Knut Krohn, Patricia Shepherd, Erika Schmidt, Sabine Leiblein, Christina Franke, Evelin Hennig, Thomas Friedrich, Reiner Krahl, Dietger Niederwieser, Michael W. N. Deininger

Blood (2003) 101 (5): 1941–1949.

https://doi.org/10.1182/blood-2002-07-2053

Published: 2003

NARROW

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Molecular Remission to Imatinib in Patients with Chronic Myeloid Leukaemia (CML) Is Less Durable Compared to Patients after Allografting.

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Emergence of clonal cytogenetic abnormalities in Ph − cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

Email alerts

ASH Publications

American Society of Hematology

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Molecular Remission to Imatinib in Patients with Chronic Myeloid Leukaemia (CML) Is Less Durable Compared to Patients after Allografting.

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Emergence of clonal cytogenetic abnormalities in Ph − cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only